Dyne Therapeutics
(NASDAQ) DYN
Dyne Therapeutics Financials at a Glance
Market Cap
$2.83B
Revenue (TTM)
$0.00
Net Income (TTM)
$446.21M
EPS (TTM)
$-3.54
P/E Ratio
-4.84
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Price
$17.10
Volume
5,758
Open
$18.43
Price
$17.10
Volume
5,758
Open
$18.43
Previous Close
$17.10
Daily Range
$17.08 - $18.86
52-Week Range
$6.36 - $25.00
Dividend
$0.00
Beta (Volatility)
1.61 (High)
Price
$17.10
Volume
5,758
Open
$18.43
Previous Close
$17.10
Daily Range
$17.08 - $18.86
52-Week Range
$6.36 - $25.00
DYN News
DYN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Dyne Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
258
CEO
John G. Cox, MBA
Website
www.dyne-tx.comHeadquarters
Waltham, MA 02451, US
DYN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-56%
Return on Capital
-41%
Return on Assets
-38%
Earnings Yield
-20.66%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.83B
Shares Outstanding
165.03M
Volume
5.76K
Short Interest
0.00%
Avg. Volume
2.25M
Financials (TTM)
Gross Profit
$2.05M
Operating Income
$468.18M
EBITDA
$437.97M
Operating Cash Flow
$403.21M
Capital Expenditure
$1.92M
Free Cash Flow
$405.13M
Cash & ST Invst.
$1.11B
Total Debt
$20.28M
Dyne Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$521.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$2.83B
N/A
Market Cap/Employee
$14.73M
N/A
Employees
192
N/A
Net Income
$111.95M
-25.0%
EBITDA
$101.23M
-4.7%
Quarterly Fundamentals
Net Cash
$1.09B
+76.3%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$15.28M
-20.1%
Short Term Debt
$5.00M
+3.0%
Return on Assets
-37.59%
N/A
Return on Invested Capital
-41.20%
N/A
Free Cash Flow
$112.32M
-31.5%
Operating Cash Flow
$111.83M
-32.6%